EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    5.1.1.4 | Neoplasms |
32820256 |
A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
4
2
0 |
| 5.1.1.4 | Infections |
24416292 |
A proline racemase based PCR for identification of Trypanosoma vivax in cattle blood. |
diagnostic usage
therapeutic application
unassigned |
3
3
0 |
| 5.1.1.4 | Chagas Disease |
12735293 |
Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. |
therapeutic application
unassigned |
4
0 |
| 5.1.1.4 | Brucellosis |
24508400 |
Brucella alters the immune response in a prpA-dependent manner. |
causal interaction
unassigned |
3
0 |
| 5.1.1.4 | Persistent Infection |
24508400 |
Brucella alters the immune response in a prpA-dependent manner. |
causal interaction
unassigned |
3
0 |
| 5.1.1.4 | Chagas Disease |
23613764 |
Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease. |
therapeutic application
unassigned |
4
0 |
| 5.1.1.4 | Prostatic Neoplasms |
28557546 |
Inflammation-associated DNA methylation patterns in epithelium of ulcerative colitis. |
causal interaction
ongoing research
unassigned |
1
4
0 |
| 5.1.1.4 | Infections |
20140365 |
Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
2
2 |
| 5.1.1.4 | Parasitic Diseases |
20140365 |
Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
2
2 |
| 5.1.1.4 | Chagas Disease |
17849014 |
Molecular and structural discrimination of proline racemase and hydroxyproline-2-epimerase from nosocomial and bacterial pathogens. |
therapeutic application
unassigned |
2
0 |
